Ketanserin

Ketanserin

Clinical data
ATC code	C02KD01 (WHO)
Identifiers
CAS Number	74050-98-9
PubChem CID	3822
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22FN3O3
Molar mass	395.43 g/mol

WikiDoc Resources for Ketanserin
Articles
Most recent articles on Ketanserin Most cited articles on Ketanserin Review articles on Ketanserin Articles on Ketanserin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ketanserin Images of Ketanserin Photos of Ketanserin Podcasts & MP3s on Ketanserin Videos on Ketanserin
Evidence Based Medicine
Cochrane Collaboration on Ketanserin Bandolier on Ketanserin TRIP on Ketanserin
Clinical Trials
Ongoing Trials on Ketanserin at Clinical Trials.gov Trial results on Ketanserin Clinical Trials on Ketanserin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ketanserin NICE Guidance on Ketanserin NHS PRODIGY Guidance FDA on Ketanserin CDC on Ketanserin
Books
Books on Ketanserin
News
Ketanserin in the news Be alerted to news on Ketanserin News trends on Ketanserin
Commentary
Blogs on Ketanserin
Definitions
Definitions of Ketanserin
Patient Resources / Community
Patient resources on Ketanserin Discussion groups on Ketanserin Patient Handouts on Ketanserin Directions to Hospitals Treating Ketanserin Risk calculators and risk factors for Ketanserin
Healthcare Provider Resources
Symptoms of Ketanserin Causes & Risk Factors for Ketanserin Diagnostic studies for Ketanserin Treatment of Ketanserin
Continuing Medical Education (CME)
CME Programs on Ketanserin
International
Ketanserin en Espanol Ketanserin en Francais
Business
Ketanserin in the Marketplace Patents on Ketanserin
Experimental / Informatics
List of terms related to Ketanserin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ketanserin is a serotonin receptor antagonist. It has the highest affinity for the serotonin 5-HT_2A receptor, but also binds less potently to the 5-HT_2C, 5-HT_2B, 5-HT_1D, alpha-adrenergic, and dopamine receptors. With tritium radioactively labeled ketanserin is used as a radioligand for the serotonin 5-HT_2A receptor, e.g. in receptor binding assays.

Ketanserin was discovered at Janssen Pharmaceutica in 1980.

It is classified as an antihypertensive by the World Health Organization and the National Institute of Health.